Pharmafile Logo
Pharmafocus logo
Advanced Search

Neuraxpharm completes its presence in Benelux by opening an affiliate in Brussels to cover Belgium and Luxembourg

January 24, 2023
Business Services

Brussels and Düsseldorf – January 24, 2023 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the …

News
Press release

Europe plans further antibiotic shortage countermeasures

January 24, 2023
Medical Communications

With respiratory infections increasing, an ongoing cost of living crisis and the Russia-Ukraine conflict, officials throughout Europe are beginning to …

News

WHO issues a “call to action” after cough syrup deaths

January 24, 2023
Medical Communications

WHO has released an urgent “call to action” to all 194 WHO member states in order to try and prevent, …

News

TheracosBio’s oral drug approved by FDA for adults with type 2 diabetes

January 24, 2023
Research and Development

TheracosBio has announced that the first oral SGLT2 inhibitor, bexaflilozin, has been approved by the FDA for the treatment of …

News

Novo Nordisk accused of violating FDA’s Fair Balance advertising policy

January 24, 2023
Sales and Marketing

Advocacy group, the Physicians Committee for Responsible Medicine, has accused Novo Nordisk of breaching FDA’s Fair Balance policy after Novo …

News

Modus Therapeutics submits patent application for sevuparin in kidney disease

January 23, 2023
Business Services

STOCKHOLM, SWEDEN – 23 January 2023: Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet …

News
Press release

Priothera announces first patients enrolled in pivotal MO-TRANS global Phase 2b/3 study with mocravimod as an adjunctive and maintenance therapy for patients with Acute Myeloid Leukemia (AML) undergoing allogeneic Hematopoietic Cell Transplant (HCT)

January 23, 2023
Business Services

Dublin, Ireland – January 23, 2023 – Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator compound …

News
Press release

First Indian intranasal COVID-19 vaccine about to launch

January 23, 2023
Medical Communications

Indian biotech company Bharat Biotech plans to launch its new intranasal COVID-19 vaccine iNCOVACC on the 26 January 2023 ‒ …

News

FDA awards CardioRenal Systems Breakthrough Device Designation for RenalGuard Therapy

January 23, 2023
Medical Communications

The FDA has granted Breakthrough Device Designation for US-based medical technology company CardioRenal for their RenalGuard Therapy device, used to …

News

FDA grants Accelerated Approval for Seagen’s colorectal cancer treatment

January 23, 2023
Research and Development

Seagen Inc has been given FDA Accelerated Approval for its colorectal drug TUKYSA (tucatinib) after reviewing positive data from the …

News

AI and motion capture technology used to monitor movement disorders

January 23, 2023
Research and Development

A team of researchers have been developing a monitoring system to assess the progression of movement disorders. The new technology …

News

FDA rejects accelerated approval for Eli Lilly’s Alzheimer’s drug, donanemab

January 20, 2023
Research and Development

Eli Lilly has announced that its accelerated approval bid for Alzheimer’s disease drug, donanemab, has been rejected by the FDA. …

News

Merck attempts to reduce levels of carcinogenic compounds in diabetes drugs

January 20, 2023
Medical Communications

Pharmaceutical company Merck has announced that it is attempting to reduce levels of a cancer-causing compound which has been found …

News

Intas Pharmaceuticals under FDA scrutiny after oversight in GMP documents

January 20, 2023
Manufacturing and Production

India-based manufacturer Intas Pharmaceuticals has been issued a Form 483 by the FDA after three investigators found a “cascade of …

News

Alnylam and PTC Therapeutics’ rare disease drugs given backing by NICE

January 20, 2023
Medical Communications

Alnylam’s Amvuttra and PTC Therapeutics’ Translarna will be available to patients through the NHS after being backed by NICE, despite …

News

Genentech announce positive results from phase 3 IMbrave050 study

January 19, 2023
Research and Development

Genentech, based in California, US, has announced positive results from its phase 3 IMbrave050 trial, after the study met its …

News

Abbott secures FDA approval for Navitor TAVI device

January 19, 2023
Medical Communications

US-based medical device firm Abbott has secured FDA approval for Navitor to treat people with aortic stenosis who are at …

News

Moderna’s mRNA vaccine appears promising for older adults with RSV

January 19, 2023
Research and Development

Moderna’s respiratory syncytial virus (RSV) vaccine has demonstrated positive levels of efficacy in older adults throughout a phase 3 trial. …

News

Johnson & Johnson cuts trial for its HIV vaccine following disappointing data

January 19, 2023
Medical Communications

Johnson & Johnson (J&J) has announced that it has ended its clinical trial for its experimental HIV vaccine, following disappointing …

News

NICE recommends AMVUTTRA®▼ (vutrisiran) as treatment for a hereditary form of amyloidosis in draft guidance

January 19, 2023
Business Services

MAIDENHEAD, UK, 19th January 2023 – Alnylam UK Limited, the leading RNA interference (RNAi) therapeutics company, today welcomed a draft …

News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025